Trials / Unknown
UnknownNCT00189644
6 FEC 100 Vs 4 FEC 100 Followed by 4 Taxol in N+ Breast Cancer
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Association Européenne de Recherche en Oncologie · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this randomized trial is to compare 6 FEC100 to 4 FEC100 + 4 Taxol in patients with resected node positive breast cancer. Main endpoint is disease free survival. Secondary endpoints are overall survival, time to local recurrence, time to distant metastases, and tolerance. A total of 840 patients have been included in the trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | 6 FEC 100 | |
| PROCEDURE | 4 FEC 100 followed by 4 Taxol |
Timeline
- First posted
- 2005-09-19
- Last updated
- 2005-09-19
Source: ClinicalTrials.gov record NCT00189644. Inclusion in this directory is not an endorsement.